本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

阿爾尼拉姆製藥公司

235.74
-26.4200-10.08%
盤後233.72-2.0200-0.86%19:19 EDT
成交量:188.16萬
成交額:4.58億
市值:305.18億
市盈率:-108.19
高:259.16
開:257.14
低:235.57
收:262.16
資料載入中...
2025/03/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/21

重要事件披露

Form 8-K - Current report
2025/03/05

重要事件披露

Form 8-K - Current report
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/13

重要事件披露

Form 8-K - Current report
2025/02/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]